STOCK PURCHASE AGREEMENTStock Purchase Agreement • May 28th, 2020 • Outlook Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
This Stock Purchase Agreement (“Agreement”) is entered into as of May 22, 2020 (the “Execution Date”), by and between Outlook Therapeutics, Inc., a Delaware corporation having an office at 4260 U.S. Route 1, Monmouth Junction, New Jersey, 08852 (“Outlook”), and Syntone Ventures LLC, a Delaware limited liability company having an office at 1517 Champlain Crest Way, Cary, NC 27513 (“Syntone”). The capitalized terms used herein and not otherwise defined have the meanings given to them in Appendix 1.
